Imricor Medical Systems (IMR) EGM 2024 summary
Event summary combining transcript, slides, and related documents.
EGM 2024 summary
23 Jan, 2026Opening remarks and agenda
Meeting opened with a welcome and instructions for voting and Q&A participation.
Quorum confirmed, meeting declared open and authorized to transact business.
Notice of meeting, proxy statement, and explanatory memorandum made available to all stakeholders.
Specific resolutions to be voted on
Ratification and approval of prior issue of 49,514,682 CDIs at AUD 0.52 per CDI under tranche one of the placement.
Approval for issue of up to 17,550,154 CDIs at AUD 0.52 per CDI under tranche two of the placement.
Approval for issue of up to 242,857 shares at $0.35 per share to accredited US investors under tranche two.
Board and executive committee updates
Introduction of four directors, CFO, and Company Secretary present at the meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Imricor Medical Systems
- Regulatory wins, clinical milestones, and $44m raised amid lower revenue and global expansion plans.IMR
H2 202524 Feb 2026 - World-first MRI-guided ablations and robust cash reserves drive global expansion.IMR
Q4 2025 TU27 Jan 2026 - Revenue up 105% and $35m AUD raised, but going concern risk persists.IMR
H1 202423 Jan 2026 - MRI-guided ablation is set for rapid adoption, backed by strong clinical results and global expansion.IMR
NWR Virtual Healthcare Conference26 Dec 2025 - Revenue up 56% with new approvals, but net loss and going concern risk remain.IMR
H2 202418 Dec 2025 - Revenue fell 52% and net loss widened, but a $44.1m equity raise strengthened liquidity.IMR
H1 202524 Nov 2025 - Board, equity, and strategic expansion resolutions passed with strong shareholder support.IMR
AGM 202521 Nov 2025 - US regulatory progress and European launch boost growth; 8 quarters of funding remain.IMR
Q3 2025 TU21 Oct 2025 - Regulatory progress, expanded pipeline, and strong cash position set stage for accelerated growth.IMR
Q2 2025 TU27 Jul 2025